Feature Exousia Pro progressing scalable DNA-loaded exosomes toward the clinic Exousia Pro (OTCPINK: MAJI) is developing a next-generation drug delivery platform using plant-based exosomes and a proprietary manufacturing process that could potentially address the biggest challenges in the... September 16, 2025